跳至主要内容
临床试验/PACTR202401827533382
PACTR202401827533382已完成Unknown

Monitoring and evaluation of molecular markers drug resistance during seasonal malaria chemoprevention with sulfadoxine-pyrimethamine and amodiaquine implementation in Koutiala, Mali

AAS0 个研究点目标入组 1,000 人开始时间: 2023年12月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • i. Child who received SP or AQ in the previous month;
  • ii. Child suffering from malaria diagnosed or under treatment at the time of implementation;
  • iii. Child with a known allergy to SP or AQ;
  • iv. adults never have taken SMC

排除标准

  • 1. Known allergy to SMC medicine
  • 2. Child with severe malaria
  • 3. Child on cotrimoxazole

研究者

发起方
AAS

相似试验